Outset Medical Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Outset Medical stock.
View analyst ratings for Outset Medical or view top-rated stocks.

Wall Street analysts have given Outset Medical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Outset Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Outset Medical saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 1,260,000 shares, an increase of 35.2% from the February 28th total of 932,000 shares. Based on an average trading volume of 315,900 shares, the days-to-cover ratio is currently 4.0 days. Currently, 3.6% of the company's stock are short sold.
View Outset Medical's Short Interest.

Outset Medical is scheduled to release its next quarterly earnings announcement on Tuesday, June 8th 2021.
View our earnings forecast for Outset Medical.

Outset Medical, Inc. (NASDAQ:OM) released its quarterly earnings results on Monday, March, 8th. The company reported ($0.75) earnings per share for the quarter, missing analysts' consensus estimates of ($0.66) by $0.09. The business earned $17.25 million during the quarter, compared to analysts' expectations of $13.79 million.
View Outset Medical's earnings history.

Outset Medical updated its first quarter 2021 After-Hours earnings guidance on Tuesday, March, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $21-22 million, compared to the consensus revenue estimate of $14.79 million.

7 Wall Street analysts have issued 1-year price targets for Outset Medical's stock. Their forecasts range from $54.00 to $60.00. On average, they anticipate Outset Medical's share price to reach $56.50 in the next year. This suggests a possible upside of 4.8% from the stock's current price.
View analysts' price targets for Outset Medical or view top-rated stocks among Wall Street analysts.

Some companies that are related to Outset Medical include Getinge (GNGBY), LivaNova (LIVN), CONMED (CNMD), InMode (INMD), BioLife Solutions (BLFS), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Semler Scientific (SMLR), ViewRay (VRAY), Stereotaxis (STXS), Cutera (CUTR), Zynex (ZYXI), Edap Tms (EDAP) and Second Sight Medical Products (EYES).
View all of OM's competitors.

(OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Outset Medical trades on the NASDAQ under the ticker symbol "OM."

Outset Medical's lock-up period expired on Monday, March 15th. Outset Medical had issued 8,951,111 shares in its IPO on September 15th. The total size of the offering was $241,679,997 based on an initial share price of $27.00. Since the expiration of Outset Medical's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted.

Outset Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Columbia Trust Co 01012016 (0.18%) and Baldwin Brothers Inc. MA (0.00%). Company insiders that own Outset Medical stock include D Keith Grossman, John L Brottem, Leslie Trigg, Martin Vazquez, Pincus X LP Warburg, Rebecca Chambers and Warburg Pincus Llc.
View institutional ownership trends for Outset Medical.

OM stock was acquired by a variety of institutional investors in the last quarter, including Columbia Trust Co 01012016, and Baldwin Brothers Inc. MA.
View insider buying and selling activity for Outset Medical or or view top insider-buying stocks.

Shares of OM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OM stock can currently be purchased for approximately $53.90.

Outset Medical has a market capitalization of $2.31 billion.

Outset Medical employs 313 workers across the globe.

The official website for Outset Medical is outsetmedical.com.

Outset Medical is headquartered at 3052 ORCHARD DRIVE, SAN JOSE CA, 95134.

Outset Medical's mailing address is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. The company can be reached via phone at 669 231 8200 or via email at [email protected]